期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Genetically modified human umbilical cord blood cells as a promising strategy for treatment of spinal cord injury 被引量:2
1
作者 Yana O. Mukhamedshina albert a. rizvanov 《Neural Regeneration Research》 SCIE CAS CSCD 2016年第9期1420-1421,共2页
Spinal cord injury (SCI) continues to be a pressing health and social problem. The injury leads to neuronal and glial cell death accompanied by degeneration of nerve fibers. There are currently no particularly effec... Spinal cord injury (SCI) continues to be a pressing health and social problem. The injury leads to neuronal and glial cell death accompanied by degeneration of nerve fibers. There are currently no particularly effective treatments. SCI causes profound disabil- ity of people affected and has attracted increased attention in the international field of neuroregeneration. For the past two decades, much hope has been placed in cell therapies for the restoration of both structure and function of the injured spinal cord. Embryonic and neural stem cells, olfactory ensheathing cells, microglia-like cells, Schwann cells, mesenchymal stem cells. 展开更多
关键词 gene cell VEGF GDNF Genetically modified human umbilical cord blood cells as a promising strategy for treatment of spinal cord injury SCI
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部